137 related articles for article (PubMed ID: 32723245)
1. Clinicopathological and Imaging Features Predictive of Clinical Outcome in Metaplastic Breast Cancer.
Yoon GY; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ; Oh HY
Curr Med Imaging; 2020; 16(6):729-738. PubMed ID: 32723245
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.
Boisserie-Lacroix M; Macgrogan G; Debled M; Ferron S; Asad-Syed M; McKelvie-Sebileau P; Mathoulin-Pélissier S; Brouste V; Hurtevent-Labrot G
Oncologist; 2013; 18(7):802-11. PubMed ID: 23821326
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
Park S; Yoon JH; Sohn J; Park HS; Moon HJ; Kim MJ; Kim EK; Kim SI; Park BW
PLoS One; 2016; 11(2):e0149347. PubMed ID: 26866475
[TBL] [Abstract][Full Text] [Related]
4. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
5. Radiologic Findings of a Rare Subtype of Invasive Breast Cancer with Poor Prognosis: Metaplastic Carcinoma of the Breast.
Aydin H; Guner B; Bostanci IE; Ciledag N; Bulut MB; Bozgul M; Dilek GB; Aribas BK
Curr Med Imaging Rev; 2019; 15(3):338-348. PubMed ID: 31989886
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.
Baek SH; Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
Acta Radiol; 2017 Dec; 58(12):1434-1441. PubMed ID: 28281788
[TBL] [Abstract][Full Text] [Related]
7. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes.
An YY; Kim SH; Kang BJ; Park CS; Jung NY; Kim JY
Eur J Radiol; 2015 Oct; 84(10):1894-902. PubMed ID: 26198117
[TBL] [Abstract][Full Text] [Related]
9. Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value?
Daniel OK; Lim SM; Kim JH; Park HS; Park S; Kim SI
Breast Cancer Res Treat; 2017 Jul; 164(2):437-444. PubMed ID: 28439735
[TBL] [Abstract][Full Text] [Related]
10. Staging of breast cancer with ultrasound.
Yang WT
Semin Ultrasound CT MR; 2011 Aug; 32(4):331-41. PubMed ID: 21782123
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.
Xu J; Li F; Chang F
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1425-1430. PubMed ID: 29043992
[TBL] [Abstract][Full Text] [Related]
12. Radiological features of triple-negative breast cancers (73 cases).
Boisserie-Lacroix M; Mac Grogan G; Debled M; Ferron S; Asad-Syed M; Brouste V; Mathoulin-Pelissier S; Hurtevent-Labrot G
Diagn Interv Imaging; 2012 Mar; 93(3):183-90. PubMed ID: 22421282
[TBL] [Abstract][Full Text] [Related]
13. Basal-like Breast Cancer: Comparison of Imaging Characteristics.
Choi BB; Jang HJ; Choi SI
Curr Med Imaging; 2020; 16(3):241-248. PubMed ID: 32133954
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of a color map pattern on shear-wave elastography for invasive breast cancer.
Lee S; Jung Y; Bae Y
Surg Oncol; 2016 Mar; 25(1):44-8. PubMed ID: 26979640
[TBL] [Abstract][Full Text] [Related]
15. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Radiological Features with Long Term Follow Up of Metaplastic Carcinoma Breast in India.
Puri G; Lohani KR; Khadka S; Kataria K; Ranjan P; Hari S; Mathur S; Dhar A; Srivastava A
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3483-3492. PubMed ID: 34837903
[TBL] [Abstract][Full Text] [Related]
17. Metaplastic carcinoma of the breast: multimodality imaging and histopathologic assessment.
Choi BB; Shu KS
Acta Radiol; 2012 Feb; 53(1):5-11. PubMed ID: 22090465
[TBL] [Abstract][Full Text] [Related]
18. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
19. Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings.
Tang X; Yamashita T; Hara M; Kumaki N; Tokuda Y; Masuda S
Breast Cancer; 2016 May; 23(3):491-8. PubMed ID: 25644245
[TBL] [Abstract][Full Text] [Related]
20. DCIS of the breast: The value of preoperative MRI.
Doyle AJ; Prakash S; Wang K; Cranshaw I; Taylor E; Oldfield R
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):194-8. PubMed ID: 26810138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
